Re-evaluating a single-arm trial of favipiravir for severe fever with thrombocytopenia syndrome in Japan: A proposal to use real-world data as external controls

Open Access

Kenji Kubo ,

* E-mail: kubokenji1010@gmail.com

Affiliation Department of Emergency Medicine and Department of Infectious Diseases, Japanese Red Cross Wakayama Medical Centre, Wakayama, Japan

https://orcid.org/0000-0002-3765-736X

⨯
Mayumi Toyama,

Affiliation Department of Health Informatics, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan
⨯
Ken-ichiro Kobayashi,

Affiliation Department of Infectious Diseases, Japanese Red Cross Wakayama Medical Centre, Wakayama, Japan
⨯
Nobuhiro Komiya,

Affiliation Department of Infectious Diseases, Japanese Red Cross Wakayama Medical Centre, Wakayama, Japan
⨯
Takeo Nakayama

Affiliation Department of Health Informatics, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan
⨯

Reader Comments (0)

Japan
Is the Subject Area "Japan" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Death rates
Is the Subject Area "Death rates" applicable to this article?

Thanks for your feedback.
Thrombocytopenia
Is the Subject Area "Thrombocytopenia" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Observational studies
Is the Subject Area "Observational studies" applicable to this article?

Thanks for your feedback.
Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.